Navigation Links
Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
Date:3/11/2009

ide of Italy;
  • The European Medicines Agency (EMEA) granted Premacure AB orphan designation for Insmed's IPLEX(TM) for the prevention of retinopathy of prematurity (ROP) in neonates of less than 32 weeks of gestational age. Premacure AB intends to initiate a phase 2 multicenter trial for IPLEX(TM) in the ROP indication during the second quarter of 2009.
  • "The sale of our FOB assets to Merck represents a watershed moment for Insmed," said Dr. Geoffrey Allan, Ph.D., President and CEO Insmed. "This agreement demonstrates Insmed's world-class clinical capabilities, and provides us with a substantial cash infusion that positions us well for future growth. In the short-term, we expect to be cash neutral for the balance of 2009 as we continue moving ahead with our IPLEX(TM) programs for MMD and ALS. In addition, we intend to pursue a comprehensive and thoughtful analysis to determine the most appropriate use of the proceeds we will receive from Merck. Our objective, though, is to utilize this capital to grow our business, and create additional shareholder value, as we have done through the transaction with Merck."

    Financial Results for Fourth Quarter and Full-year 2008

    Revenues for the fourth quarter ended December 31, 2008 were $2.9 million, up from $2.1 for the corresponding period in 2007. The increase was mainly attributable to an $846,000 increase in cost recovery revenue from our EAP to treat patients with ALS in Italy.

    The net loss for the fourth quarter of 2008 was $4.0 million or $0.03 per share, compared with a net loss of $3.3 million or $0.03 per share in the fourth quarter of 2007.

    R&D expenses increased to $5.4 million from $4.6 million, reflecting an increase in clinical trial activity for our FOB and IPLEX(TM) programs. SG&A Expenses increased to $1.3 million from $0.9 million, du
    '/>"/>

    SOURCE Insmed Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
    2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
    3. Insmed to Appeal Delisting Notification From Nasdaq
    4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
    5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
    6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
    7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
    8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
    9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
    10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
    11. Insmed to Present at CBI Follow-On Biologics Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... Calabasas, CA (PRWEB) July 24, 2014 ... advancing the Global Supply Chain of the biotech ... annual SCM Innovation Awards, brought to you by ... premiere global organization of supply chain management professionals ... be given to stakeholders of the Biotech industry ...
    (Date:7/24/2014)... team led by group leader Yung-Eun Sung has ... synthesize sulfur-doped and nitrogen-doped graphenes which can be ... and fuel cells. Yung-Eun Sung is both a ... at Institute for Basic Science* (IBS) and a ... achievement has great significance with regards to the ...
    (Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
    (Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
    Breaking Biology Technology:Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
    ... German . The heat which occurs in ... even a problem. On the contrary: It could be used ... more efficiently! These are two of the several potential applications ... (PTB). This so-called "thermoelectric voltage" may well be very interesting ...
    ... Spherix Incorporated (NASDAQ: SPEX ) ... diabetes, metabolic syndrome and atherosclerosis, and providers of ... biotechnology and pharmaceutical companies -- today announced that ... dyslipidemia in new studies of apolipoprotein E-deficient mice ...
    ... Oct. 24, 2011 Reaction Biology Corporation ("RBC"), ... services in epigenetics, today announced the rollout of ... research. RBC,s initial offerings will emphasize the histone ... has been no previous commercial source. ...
    Cached Biology Technology:Magnetic nanoswitch for thermoelectric voltages 2Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight 2Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight 3Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight 4Reaction Biology Launches Recombinant Methyltransferase Line 2
    (Date:7/25/2014)... scars on this false-color image from the Terra satellite show ... rash of wildfires in Eastern Russia. The burn scars ... background. The wildfires have broken across the remote parts ... this false-color image from the MODIS instrument, it is ... that continue. Two recent image features noted below show the ...
    (Date:7/25/2014)... the International Journal of Cancer earlier this ... based on findings showing successful reduction in the risk ... of cells in the cervix. , The findings ... cells, or SCJ cells. These cells reside in the ... of cervical cancer. A research team co-led by Christopher ...
    (Date:7/25/2014)... and Diabetes increasingly consume the healthcare community ... attention. , To address the worldwide ... low-and middle-income countries, global leaders in diabetes, ... in diabetes prevention and development of diverse ... text. , This book on "Global ...
    Breaking Biology News(10 mins):Clearing cells to prevent cervical cancer 2What constitutes an effective response to the global 'diabesity' tsunami? 2
    ... highways or drive down any city street this ... manicured beds of flowers maintained by community volunteers ... gardens are taking root. Aside from the ... including landscaping and gardens, can help drivers reduce ...
    ... University doctoral student Jennifer Smith has shed new light on ... hunt for their food alone. In a paper ... a student in MSU,s Department of Zoology, shows that while ... cooperative societies, they also realize that venturing on their own ...
    ... 28, 2008The 2008 American Society for Microbiology (ASM) ... being presented to Stephen C. Edberg, Professor, Department ... School of Medicine, and Director, Clinical Microbiology Laboratory, ... this award recognizes a distinguished scientist for research ...
    Cached Biology News:New roadside beautification concept studied 2Spotted hyenas can increase survival rates by hunting alone 2American Society for Microbiology honors Stephen C. Edberg 2
    ... ESGRO Complete Derivation Kit is intended ... cells from delayed blastocysts in serum-free ... Clonal Grade ... Blastocyst Incubation Medium Trypsin Solution ...
    AedestaTM Animal Organ/Tissue Perfusion Soln....
    RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
    casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
    Biology Products: